Trials / Withdrawn
WithdrawnNCT03912116
Amniotic Umbilical Cord Particulate During Total Knee Arthroplasty
Adjunctive Use of Amniotic Umbilical Cord Particulate During Total Knee Arthroplasty
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- BioTissue Holdings, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Total knee arthroplasty (TKA) is the most common joint replacement surgery and its incidence is expected to increase 673% to 3.48 million procedures annually by 2030. After more than 20 years of follow-up data, TKA is confirmed to be an effective treatment for knee osteoarthritis, however, postoperative pain management continues to be a challenge despite advances in surgical techniques and anesthetic practice to minimize discomfort and enhance recovery. This acute post-surgical pain caused by extensive tissue damage and inflammation in TKA leads to restricted post-operative knee range of motion (ROM) and ability to mobilize.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | CLARIX FLO | 100mg CLARIX FLO |
| OTHER | Saline | Saline |
Timeline
- Start date
- 2019-04-09
- Primary completion
- 2019-12-16
- Completion
- 2019-12-16
- First posted
- 2019-04-11
- Last updated
- 2019-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03912116. Inclusion in this directory is not an endorsement.